Labiotech.eu

News and Trends 28 Oct 2015

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

We still haven’t fully sequenced the domestic wheat genome! Now the US Dragen chip has the answer for speedy whole-genome analysis, which The Genome Analysis Centre (TGAC) in England will test out for UK food-security research. Dragen is a Bio-IT platform processing chip which has clinical pipelines for many areas in research, including the Microbiome, […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon is now underway, with the launch of a new genomics eCommerce webshop and the expansion of their headquarters. Horizon Discovery provides personalized translational medicine products and services, such as bespoke cell-lines for drug discovery and […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Bath, in South West England, has a lot more besides its historic beauty…The Jenkins Chemistry lab at the University of Bath has a fair few innovative solutions to the problem of infectious disease detection. Their latest design is a burns dressing which glows when a pathogenic biofilm is detected (as part of the Bacteriosafe Project) […]

October 28, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

The Belgian biomanufacturing company Univercells and the Japanese pharmaceutical company Takeda have signed a strategic partnership agreement. Univercells has closed a €3M equity investment with Takeda Ventures to produce affordable vaccines. Univercells provides single-use cost-efficient bioprocess solutions to lead the next generation in biomanufacturing. Under the terms of the agreement, the two biotechs will launch a […]

October 27, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Karen Aiach had no background in science or the biotech industry, yet when her daughter Ornella was diagnosed with the super-rare Sanfilippo syndrome this inspired her to co-found and become the CEO of Lysogene, today a clinical-stage biotech based in Paris, France. Now Ornella is participating in the ongoing clinical trials for a new gene […]

October 27, 2015 - 7 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

CRIPSR’s hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing tool, which almost won the Nobel Prize of this year (it won nearly all the other biology prizes already). It also caught great interest from the industry and venture capitalists. The leading Biotechs includes: Editas, Boston-based and clozed a $120M found […]

October 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Oct 2015

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The fight against Alzheimer‘s with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry specialists also wanting in on the battle front. The latest development in the Dementia Discovery Fund (DDF) includes US Biogen‘s dramatic cuts to redirect $250M into the Neurodegenerative disease venture, and investment into $100M ‘A’ […]

October 26, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

The First Ever Oncolytic Immunotherapy is Set to Reach the European Market

Amgen is now months away from a European approval with Imlygic (also known as T-VEC) – the first oncolytic immunotherapy for advanced melanoma. The Committee for Medicinal Products for Human Use (CHMP) and the scientific committee of the European Medicines Agency (EMA), have reacted positively. Melanoma is a type of skin cancer that is characterized by the uncontrolled growth of melanocytes, […]

October 26, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 26 Oct 2015

Financial Storm approaching? EU Biotechs start postponing their IPOs in London …

Biotech financing beats record over record since beginning of 2014. Financing has never been as high in Europe (though of course, we know this has always been the case for the US). Just look at Neil Woodford, famous british investor who raised €1.1Bn for its fund and injected it in many companies like Immuncore (2nd biggest VC round […]

October 26, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 24 Oct 2015

What Happened this Week? Ultimate Cancer Review, Biofuels, Microalgae

Monday: Monster €167M NASDAQ-IPO coming for Swiss Antibiotic Biotech Basilea Tuesday: The Ultimate Review on how Biotech Changed Cancer Treatment Wednesday: “CAR-T / TCR Deserves to have a lot of Money because the Data is Very Exciting” Thursday: Aquanos Algae: Israeli Start-up fixes the Global Sustainability issue in Recycling Sewage Water Friday: #Sorry: The World-leading Oncology Company […]

October 24, 2015 - 1 minutemin - By Philip Hemme

News and Trends 23 Oct 2015

#Sorry: The World-leading Oncology Company fails in Phase III

Antibody Drug Conjugate is a smart way to improve chemotherapy. That is the strategy of Roche / Immunogen‘s drug Kadcyla®, which has just failed in Phase III clinical trial to extend its indications. Here are the facts… Antibody Drug Conjugate is at the boundary between chemical and biological drug. The principle is pretty simple; once the antibody fixes to […]

October 23, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 23 Oct 2015

Novartis Monopolises Immuno-Oncology: Three More Biotechs taken Under its Wing

Novartis, the Swiss Biotech giant, has once again broadened its Immuno-oncology portfolio with the acquisition of US Admune Therapeutics (MA) and forming marketing, commercialization and development partnerships with California’s Xoma and Palobiopharma in Barcelona (Spain). Novartis is a Basel giant in the biotech industry, with their research development programs spanning a broad range of fields […]

October 23, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The First Ever Oncolytic Immunotherapy is Set to Reach the European Market

Financial Storm approaching? EU Biotechs start postponing their IPOs in London …

What Happened this Week? Ultimate Cancer Review, Biofuels, Microalgae

#Sorry: The World-leading Oncology Company fails in Phase III

Novartis Monopolises Immuno-Oncology: Three More Biotechs taken Under its Wing

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!